Longitudinal recovery and self-efficacy in first-episode schizophrenia: insights from a 10-year follow-up study

A significant proportion of first-episode schizophrenia patients can achieve clinical recovery. While these positive outcomes are noteworthy, it is important to recognize that recovery paths can vary widely among individuals. Since people with schizophrenia are concerned about their chances of recovery, the results must be shared with patients and their families. While the causal relationship between self-efficacy and recovery remains unclear, they likely influence each other.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2025-06-16
DOI
https://doi.org/10.3389/fpsyt.2025.1588349
Citations
1
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Longitudinal recovery and self-efficacy in first-episode schizophrenia: insights from a 10-year follow-up study

Nikolai Olavi Czajkowski, Christine Mohn, Anne‐Kari Torgalsbøen, Frank Larøi
1 citations
Frontiers in Psychiatry
Schizophrenia research and treatment
1.47
article

Longitudinal recovery and self-efficacy in first-episode schizophrenia: insights from a 10-year follow-up study

Nikolai Olavi Czajkowski, Christine Mohn, Anne‐Kari Torgalsbøen, Frank Larøi
article en
1 citations

Abstract

A significant proportion of first-episode schizophrenia patients can achieve clinical recovery. While these positive outcomes are noteworthy, it is important to recognize that recovery paths can vary widely among individuals. Since people with schizophrenia are concerned about their chances of recovery, the results must be shared with patients and their families. While the causal relationship between self-efficacy and recovery remains unclear, they likely influence each other.

Frontiers in PsychiatryVol. 16
Norwegian Institute of Public Health (NO), University of Liège (BE), OsloMet – Oslo Metropolitan University (NO), University of Oslo (NO)
Universitetet i Oslo
Openalex Percentile: Top 18%
Schizophrenia research and treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.